Is the safety of contrast agents an issue in body computed tomography?

RATIONALE AND OBJECTIVES: To investigate the comparative safety profiles of nonionic and ionic contrast agents in body computed tomography (CT) studies. METHODS: A literature search was conducted to examine the following variables: image quality, repeat or aborted studies, and the cost of nonionic agents versus benefits. Data are presented that address the following questions: Does administering nonionic agents save time? Are nonionic agents more likely to provide an adequate study? Does an adequate study necessarily ensure an improved detection rate? RESULTS: The administration of nonionic contrast does not save time during the body CT studies. There is little significant difference between the sensitivity for making a diagnosis when using an ionic or nonionic agent. CONCLUSION: The lack of difference in diagnostic sensitivity or time to perform a study between ionic and nonionic agents does not warrant the conversion to nonionic agents in body CT.

Renal transplant rejection. Limited value of duplex Doppler sonography.

Over a two-year period, 275 duplex Doppler ultrasound (US) examinations were performed on 75 renal allograft recipients. Retrospective visual analysis of the Doppler tracings was compared to concurrent clinical findings and to biopsy results. One hundred eight of the 176 Doppler examinations (61%) that showed acute rejection clinically or histologically were interpreted as rejection, while 80 of 99 examinations (81%) in clinically normal patients were interpreted as normal. Two hundred thirty-four examinations had resistive index (RI) calculations. Seventy-two of 141 examinations (51%) with RI less than 0.70 had clinical or biopsy evidence of rejection. Studies compared with only concurrent biopsies revealed that 35 of 39 US examinations interpreted as rejection were confirmed histologically, but only one of 32 examinations that appeared normal sonographically was histologically normal. The low sensitivity of Doppler US, whether by waveform analysis or RI calculation, makes it a poor screening test for acute rejection. The findings support the conclusion that Doppler sonography cannot replace biopsy in the evaluation of renal transplant dysfunction, particularly when the waveform analysis is normal and the RI less than 0.70.

Delayed magnetic resonance hepatic imaging with gadolinium-DTPA.

Magnetic resonance imaging of the liver was performed on 11 rabbits (3-5 kg) before and at 4, 5 and 6 hours after the intravenous administration of 0.3 mM/kg Gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) to determine if hepatocytes exhibit delayed excretion of Gd-DTPA, similar to the delayed hepatic excretion of iodinated contrast agents. Imaging was performed at 0.5 Tesla in the axial plane using a spin echo sequence of TR/TE, 250/20 milliseconds. Precontrast and postcontrast intensity changes for liver and muscle were standardized and compared over time. The average percent of postcontrast enhancement for liver and muscle, respectively was: 30.6 +/- 9.5% and 17.3 +/- 17.0% immediately postcontrast; 9.7 +/- 13.6% and 1.6 +/- 13.8% at 4 hours; 9.6 +/- 7.8% and 4.3 +/- 13.2% at 5 hours; and 11.0 +/- 7.8% and 4.1 +/- 11.7% at 6 hours. We conclude that there is not significant hepatocyte excretion of Gd-DTPA at 4 to 6 hours postcontrast injection in rabbits and that this may not be an advantageous paramagnetic contrast strategy for focal hepatic lesion detection.

Manganese dipyridoxyl diphosphate. Effect of dose, time, and pulse sequence on hepatic enhancement in rats.

We used an animal model to investigate the hepatic enhancement characteristics of manganese dipyridoxyl diphosphate (MnDPDP) related to time, dose, and pulse sequence. The contrast doses selected were in the human tolerance range. Using an SE 300/15 pulse sequence, maximum mean hepatic enhancement of 45% (8 mumols/kg) and 58% (12 mumols/kg) over baseline was seen during a plateau maintained between 5 and 50 minutes postinjection in the 8 mumols/kg group, and between 10 and 90 minutes in the 12 mumols/kg group. This plateau was followed by a very gradual decline in hepatic enhancement. Using either 4 or 8 mumols/kg, there was a significant increase in postcontrast hepatic intensity on all relatively T1-weighted pulse sequences (spin echo [SE] 300/15, inversion recovery [IR] 1400/20/400, gradient echo [GE] 47/13/80 degrees, and GE 60/20/30 degrees) except GE 47/13/80 degrees at 4 mumols/kg. At 8 mumols/kg there was superior enhancement, with IR 1400/20/400 and SE 300/15, but at 4 mumols/kg there was no consistently superior sequence. None of the relatively T2-weighted pulse sequences (SE 2000/50, SE 2000/100, or GE 100/30/20 degrees) demonstrated a significant change in hepatic intensity using either dose of contrast. The data suggest that the best combination of dose, pulse sequence, and time for hepatic imaging with MnDPDP is 8 mumols/kg using heavily T1-weighted sequences 5 to 60 minutes following contrast administration.

Renal corticomedullary junction. Performance of T1-weighted MR pulse sequences.

Inability to demonstrate the renal corticomedullary junction (CMJ) on magnetic resonance (MR) images has been reported in connection with several medical renal diseases. T1-weighted spin echo pulse sequences have been advocated to demonstrate a signal intensity difference between cortex and medulla. This study was undertaken to determine which of several T1-weighted spin echo (SE) and gradient echo (GE) sequences are better for delineation of the CMJ. The MR studies were performed at 0.5 Tesla on 27 normal volunteers. Multi-slice axial images of both kidneys were obtained in all subjects at each of the following five pulse sequences: SE 250/20, SE 500/30, SE 900/30, and GE 300/15 with 80 degrees and 64 degrees flip angles. Contrast/noise ratios were calculated for the signal intensity differences between cortex and medulla; the average standardized contrast/noise ratios ranked as follows: GE 300/15/80 degrees = 3.01 +/- 0.74, GE 300/15/64 degrees = 2.72 +/- 0.74, SE 250/20 = 2.02 +/- 0.33, SE 500/30 = 1.96 +/- 0.51, and SE 900/30 = 1.71 +/- 0.39. In addition, the five sequences for each patient were randomized and the images were independently ranked for delineation of CMJ by three MR radiologists. The cumulative subjective ranking for all observers from best to worst is as follows: SE 500/30, GE 300/15/80 degrees, GE 300/15/64 degrees, SE 900/30, SE 250/20. Although better contrast/noise ratios are achieved with the GE sequences and the more T1-weighted SE sequences, as a practical matter this does not seem to be the only significant factor when compared with the visual image evaluation by independent observers.(ABSTRACT TRUNCATED AT 250 WORDS)

Bilateral adrenal metastasis: "head light" sign.

Metastatic lesions to the adrenal gland are usually silent, although their incidence is especially high in patients with carcinomas of the breast and lung, and melanoma. After reviewing the sonograms of over 50 patients with adrenal masses, 10 were found to have bilateral metastases. This has prompted us to describe the "head light" sign as an accurate method for diagnosing bilateral adrenal metastases.

Suprarenal mass and its differential diagnosis.

Nine cases of suprarenal masses without endocrine abnormalities are presented: 2 adrenal pseudocysts, 2 adrenal myelolipomas, 2 neuroblastomas, 1 lymphoma metastatic to the adrenal glands, 1 teratoma, and 1 adrenal cortical carcinoma metastatic to the contralateral gland. The clinical and radiologic findings are discussed. Noninvasive and invasive procedures and their usefulness in diagnosing masses in the suprarenal area are reported. The importance of metastases to the adrenal glands in the differential diagnosis of suprarenal masses was investigated by reviewing the autopsies done from January through June, 1979, at The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas. Adrenal metastases were found in 26 per cent of the cases studied. Breast and lung carcinomas and lymphomas were the most commonly found neoplasia. The relative incidence of microscopic and macroscopic metastases in all patients with tumor is discussed.

Abscess drainage in the genitourinary tract.

This article deals with the diagnosis of perirenal fluid collections as well as renal abscesses. Proper diagnostic and drainage techniques are discussed, as are patient selection, route selection, catheter selection, technique, and catheter management. In addition, the cure rates of the therapeutic procedure are reviewed.

Magnetic resonance imaging of the liver.

Hepatic MRI has become a useful imaging modality in recent years. As with all diagnostic imaging, the scanning techniques available for hepatic MRI are manifold and complex. The article discusses these techniques and their practical applications. Contrast agents and the MR appearances of various pathologic hepatic entities are also reviewed.

Gd-DTPA adrenal gland enhancement at 1.5 T.

The change in relative signal intensity of normal adrenal glands in 31 patients was evaluated following bolus administration of 0.1 mmol/kg of gadolinium diethylenetriamine pentacetic acid (Gd-DTPA). A marked increase in relative intensity of greater than 300% was observed within 2.5 min following contrast administration upon comparison of pre- and postcontrast T1-weighted gradient-echo images (TR = 47 msec, TE = 13 msec, pulse angle 80 degrees). Significantly elevated relative intensities of 55% and 44% persisted on postcontrast T1-weighted spin-echo images obtained at further delay times averaging 8 and 20 min, respectively, when compared to the identical precontrast sequence.

Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide.

BMS 180549 (previously AMI-227), an ultrasmall superparamagnetic iron particulate agent, was investigated to determine its utility as a contrast agent on T1-weighted, as well as T2-weighted sequences, as a function of route of administration, (intravenous versus selective arterial) and concentration. Twelve farm pigs were divided into three groups of four each by route of administration (intravenous, selective superior mesenteric, or selective hepatic arterial injection). 10 mumol/kg and 20 mumol/kg dosages were given and evaluated both immediately after and 20-24 hr after contrast infusion, using both spin-echo and gradient-echo T1 and T2-weighted sequences. Significant postcontrast liver and spleen enhancement was noted at both concentrations, regardless of route of administration on both T1- and T2-weighted sequences. The earliest postcontrast T1-weighted sequence obtained during the 1-3 min interval following IV administration of high dose (20 mumol/kg) contrast demonstrated an average of +42.8% liver and +249.0% spleen enhancement; 24 hr later this decreased to 0 and 7.2%, respectively. The earliest postcontrast T2-weighted sequence obtained during the 8-17 min interval post high-dose IV contrast showed an average of -75.8% decrease in liver and -28.7% decrease in spleen signal intensity; 24 hr later the magnitude of these changes diminished to -33.1% and +2.5%, respectively. No significant difference was noted in liver or spleen enhancement, regardless of route of contrast administration (intravenous versus intraarterial).

Are hepatic and muscle T2 values different at 0.5 and 1.5 Tesla?

In an effort to determine whether T2 values of liver and muscle change with increasing field strength, 144 abdominal MR examinations were retrospectively evaluated. These patients were evaluated with a dual echo T2-weighted spin-echo sequence. Eighty-two of the examinations were performed at 0.5 Tesla and 72 at 1.5 Tesla (T). Eleven of the patients were evaluated with both MR systems with the same sequences. T2 values were also obtained from a Fe NH4(SO4)2 12H2O phantom. The T2 values of liver decreased from 57.8 +/- 11.3 at 0.5 T to 43.7 +/- 8.3 at 1.5 T. The T2 values of muscle decreased from 44.2 +/- 9 at 0.5 T to 35.4 +/- 7.2 at 1.5 T. Patients who were examined on both systems also demonstrated a decrease in both liver and muscle T2 values. For concentrations in the range of hepatic T2's, the phantom demonstrated a decrease in T2 values from 0.5 to 1.5 T ranging from 20.3 to 23.4%. All the T2 changes were statistically significant (p less than .05). The findings suggest that T2 values may depend on field strength, or may vary due to other hardware-related differences.

Time versus density enhancement of liver, spleen, and great vessels following rapid intravenous infusion of perflubron emulsion.

RATIONALE AND OBJECTIVES: We studied hepatosplenic enhancement in rhesus monkeys for 5 hr after rapid administration of perflubron (perfluorooctyl bromide [PFOB]) in an attempt to determine a clinically useful imaging window. METHODS: Five rhesus monkeys were examined using perflubron emulsion, 90% w/v perfluorochemical administered intravenously at a dose of 1.5 ml/kg and rate of 0.5 ml/sec. Helical computed tomography examination of the abdomen was obtained prior to the contrast bolus and 5 min, 30 min, 1, 2, 3, 4, and 5 hr postcontrast. Mean density of liver, spleen, and aorta was measured at each time interval. RESULTS: Significant aortic enhancement of 53 +/- 7 Hounsfield units (HU) (p < .0001) and liver enhancement of 19 +/- 4 H (p < .0004) occurred after 5 min and did not change significantly (p > .05) over 5 hr. Splenic enhancement of 35 +/- 9 HU was significant at 5 min (p < .0001) and continued to increase for 5 hr. CONCLUSION: Enhancement of the liver, blood vessels, and spleen is rapid and persists for at least 5 hr, which suggests a wider temporal window for hepatosplenic imaging with perflubron than is currently available with iodinated contrast agents.

Perfluoroctyl bromide as a blood pool contrast agent for computed tomographic angiography.

RATIONALE AND OBJECTIVES: We determined whether perfluoroctyl bromide (perflubron) could be used as a computed tomography (CT) angiographic agent by studying vessel visibility (celiac artery, superior mesenteric artery [SMA], and renal arteries) with spiral CT and three-dimensional (3D) reconstructions. METHODS: Five rhesus monkeys were examined with a perflubron emulsion (90% [w/v] perfluorochemical; administered intravenously at a dose of 1.5 ml/kg and at a rate of 0.5 ml/sec. Spiral CT was performed immediately and at 5 hr after injection. Three dimensional images of the aorta at the level of the celiac artery, SMA, and renal arteries were reconstructed and blindly rated 0-4 (0 = not seen; 4 = excellent visualization) by two observers. RESULTS: All the vessels had the best ratings immediately after injection: celiac artery, 2.8 +/- 0.42; SMA, 2.7 +/- 0.48; left renal artery, 2.1 +/- 0.99; and right renal artery, 1.2 +/- 1.03. The ratings after the 5-hr delay were as follows: celiac artery, 1.3 +/- 1.34; SMA, 1.5 +/- 1.08; left renal artery, 1.5 +/- 0.97; and right renal artery, 1.2 +/- 0.79. CONCLUSIONS: Spiral CT angiography with a perflubron emulsion successfully demonstrated all vessels immediately and at 5 hr after contrast agent infusion. Further refinements of the dose, rate, and reconstruction technique are expected to increase vessel visibility over this wide imaging window.

Transthoracic needle aspiration biopsy in Wegener's granulomatosis. Morphologic findings in five cases.

Percutaneous needle aspiration biopsies of the lung from five patients with Wegener's granulomatosis were reviewed. Three of the patients presented with the generalized form of the disease while two presented with the limited pulmonary form; one of the latter subsequently developed disseminated disease. The morphologic findings in the pulmonary aspirates were similar in all cases. The cytologic preparations contained neutrophils entrapped within necrotic debris plus scattered but prominent histiocytic giant cells, which often had nuclei arranged in rings or horseshoes, in a background of lymphocytes, epithelioid histiocytes and reactive pneumocytes. Cell block preparations showed discrete areas of necrosis containing a neutrophilic infiltrate and focally palisaded by epithelioid histiocytes. The intervening viable tissue contained prominent histiocytic giant cells and chronic inflammatory cells enmeshed in a fibrous matrix. One cell block contained a small artery with a small focus of possible granulomatous arteritis. While an open lung biopsy is generally required for a definitive diagnosis, the pathologist may encounter unsuspected Wegener's granulomatosis in a needle aspirate. Recognition of the findings observed in these cases should alert the pathologist to the possibility of Wegener's granulomatosis so that an open lung biopsy can be performed if clinically indicated and cytotoxic therapy can be promptly instituted if the diagnosis of this entity is confirmed.

Interventional computed tomography.

Due to the development and refinement of computed tomography (CT), sonography, and interventional techniques, the field of interventional radiology has seen tremendous growth in recent years. In particular, the precise anatomic detail provided by CT and sonography has allowed percutaneous biopsies and abscess drainages to be performed safely and effectively. Percutaneous biopsies are now becoming the most common interventional radiographic procedures in many institutions. The usual indications for a biopsy are to determine the etiology of a mass, neoplasm, or inflammation, and to determine whether masses in known oncologic patients represent scarring or residual viable tumor. Accuracy rates for most percutaneous CT-directed biopsies are well over 90%, and the complication rate is very low. CT-directed percutaneous abscess drainages are also safe and effective and, in most cases, will be preferable to surgical drainage. The initial indications for percutaneous drainage (single, unilocular fluid collections) have been greatly expanded to include multiloculated collections, interloop abscesses, periappendiceal abscesses, and even percutaneous cholecystotomies. Biopsy and drainage procedures, together with their accuracy rates, indications and complications, are reviewed in this monograph.